Mental health, bias, and trauma shape sexual health visits, and histories should assess function, not just risk, according to ...
Soma Mandal, MD, MSCP, says removing MHT boxed warnings is overdue but calls for transparency on the FDA's product-specific ...
Kanchi Chadha, MD, FACOG, MSCP, supports reconsidering MHT boxed warnings but says the FDA cited no study behind the change.
CMS' proposed G-codes, which experts stated would cause confusion in combination with the AMA's proposed codes, were not ...
The October 30 update from the FDA follows the February 12, 2026 labeling changes to 6 menopausal hormone therapy products in which the agency also removed safety-related boxed warnings.
Swanson, PhD, on a pilot in which integrative group medical visits improved menopause symptoms, knowledge, and self-efficacy.
Chrisandra Shufelt, MD, on why menopause is a window for cardiovascular prevention and the risk factors OB/GYNs should assess ...
HRSA will award up to $1 million to a single organization to update the Women's Preventive Services Guidelines through the new WISH program.
This FAQ summarizes a Special Report discussion of what the evidence does and does not establish about testosterone therapy ...
Chrisandra L. Shufelt, MD, MS, FACP, MSCP, professor and chair of the Division of General Internal Medicine and associate ...
Nearly half of menopausal sleep disruption tracks with nighttime hot flashes, while the remainder appears independent, making ...
Sleep disturbance is often the most bothersome symptom of the menopause transition, yet it frequently goes unreported unless ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results